NAGIOS: RODERIC FUNCIONANDO

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

dc.contributor.author	Gil Guillén, Vicente F.	es_ES
dc.contributor.author	Orozco Beltrán, Domingo	es_ES
dc.contributor.author	Redón i Más, Josep	es_ES
dc.contributor.author	Pita Fernandez, Salvador	es_ES
dc.contributor.author	Navarro-Pérez, Jorge	es_ES
dc.contributor.author	Pallarés, Vicente	es_ES
dc.contributor.author	Valls, Francisco	es_ES
dc.contributor.author	Fluixa, Carlos	es_ES
dc.contributor.author	Fernández, Antonio	es_ES
dc.contributor.author	Martín Moreno, José María	es_ES
dc.contributor.author	Pascual-de-la-Torre, Manuel	es_ES
dc.contributor.author	Trillo-Mata, Jose Luis	es_ES
dc.contributor.author	Durazo Arvizu, Ramón	es_ES
dc.contributor.author	Cooper, Richard	es_ES
dc.contributor.author	Hermenegildo, Marta	es_ES
dc.contributor.author	Rosado, Luis	es_ES
dc.date.accessioned	2015-06-29T10:34:10Z
dc.date.available	2015-06-29T10:34:10Z
dc.date.issued	2010	es_ES
dc.identifier.citation	BMC Public Health Vol. 10 pp. 717-717	es_ES
dc.identifier.uri	http://hdl.handle.net/10550/44804
dc.description.abstract	BackgroundThe Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with observed during 5 years follow-up study.Methods/DesignA cohort prospective 5 years follow-up study has been designed including 25000 patients with hypertension, diabetes and/or dyslipidemia attended in usual clinical practice. All information is registered in a unique electronic health recording system (ABUCASIS) that is the usual way to register clinical practice in the Valencian Health System (primary and secondary care). The system covers about 95% of population (near 5 million people). The system is linked with database of mortality register, hospital withdrawals, prescriptions and assurance databases in which each individual have a unique identification number. Diagnoses in clinical practice are always registered based on IDC-9. Occurrence of CV disease was the main outcomes of interest. Risk survival analysis methods will be applied to estimate the cumulative incidence of developing CV events over time.DiscussionThe Escarval-Risk study will provide information to validate different cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia from a low risk Mediterranean Region, the Valencia Community.	es_ES
dc.title	Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia	es_ES
dc.type	journal article	es_ES
dc.identifier.doi	10.1186/1471-2458-10-717	es_ES
dc.identifier.idgrec	064993	es_ES
dc.identifier.idgrec	066808